Solid Tumours
Mostrando 1-12 de 51 artigos, teses e dissertações.
-
1. Clinical, pathological and therapeutic findings on lingual rhabdomyosarcoma in a dog - case report
RESUMO O comportamento biológico dos tumores varia de acordo com a espécie animal, a localização na cavidade, a fase clínica e a natureza histopatológica. As neoplasias orais são geralmente incomuns em animais de companhia. Os rabdomiossarcomas são formações malignas, sólidas e agressivas, com alto potencial metastático. Os sinais clínicos são
Arq. Bras. Med. Vet. Zootec.. Publicado em: 13/12/2019
-
2. Microbiological and host features associated with corynebacteriosis in cancer patients: a five-year study
During a five-year period, 932 clinical isolates from cancer patients treated in a Brazilian reference centre were identified as corynebacteria; 86% of the cultures came from patients who had been clinically and microbiologically classified as infected and 77.1% of these patients had been hospitalised (71.1% from surgical wards). The adult solid tumour was t
Memórias do Instituto Oswaldo Cruz. Publicado em: 2009-09
-
3. A numerical study about the determination of parameters in an incompressible and linearly elastic solid / Estudo numérico sobre a determinação de parâmetros em um sólido elástico-linear e incompressível
The theory of classical linear elasticity is used to model of problems in medical physics that are related to the determination of elastic parameters of biological tissues from the measurement in vivo, or, in vitro of either displacements or strains. Based on experimental observations, which indicate that the abnormal biological tissues have different mechan
Publicado em: 2008
-
4. Topoisomerase ll-a e Her-2 em tumores malignos de mama e de ovário
Introdução. O receptor epidérmico humano 2 (Her-2) e a topoisomerase-IIα (T2A) são dois marcadores biológicos importantes, ambos tendo um valor prognóstico e preditivo potencial em pacientes com tumores sólidos. A amplificação dos genes Her- 2 e T2A são eventos independentes, embora o último seja mais frequente em tumores com amplificação do He
Publicado em: 2007
-
5. Molecular classification of solid tumours: towards pathway-driven therapeutics
The last decade has witnessed unprecedented developments in the genetic and epigenetic analyses of solid tumours. Transcriptional and DNA copy-number studies have improved our understanding and classification of solid tumours and highlighted the patterns of genomic aberrations associated with outcome. The identification of altered transcriptional and transla
Nature Publishing Group.
-
6. Tissue preparation for simultaneous flow cytometric quantitation of tumour associated antigens and DNA in solid tumours.
A multiparameter flow cytometric assay for the simultaneous study of tumour associated antigens (TAA) and DNA in fresh solid tumours was devised. Cell suspensions were prepared by disaggregating unfixed solid tumour samples mechanically over a stainless steel mesh. Indirect immunofluorescence was used to identify the TAA, and DNA was stained with propidium i
-
7. Current status of sentinel lymph node biopsy in solid malignancies
Lymphatic mapping and sentinel lymph node biopsy were first reported in 1977 by Cabanas for penile cancer. Since that time, the technique has become rapidly assimilated into clinical practice. The sentinel node concept has been validated in cutaneous melanoma and breast cancer. However, follow-up data of patients from randomised trials is needed to establish
BioMed Central.
-
8. Chromosome studies of solid tumours.
-
9. Prevention of febrile neutropenia: use of prophylactic antibiotics
Febrile neutropenia (FN) causes significant morbidity and mortality in patients receiving cytotoxic chemotherapy and can lead to reduced chemotherapy dose intensity and increased overall treatment costs. Antibiotic prophylaxis reduces the incidence of FN. Recent research and meta-analyses confirm that prophylactic fluoroquinolones decrease FN and infection-r
Nature Publishing Group.
-
10. Medical genetics: advances in brief: Comparative genomic hybridization for molecular cytogenetic analysis of solid tumours
-
11. Human monoclonal antibodies targeting carbonic anhydrase IX for the molecular imaging of hypoxic regions in solid tumours
Nature Publishing Group.
-
12. Phase I trial of vorinostat and doxorubicin in solid tumours: histone deacetylase 2 expression as a predictive marker
Nature Publishing Group.